Bioverge Funds, Octant I, LLC — Form D
Bioverge Funds, Octant I, LLC of BOISE, ID, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-02-23. The offering totals $250K, of which $224K was reported sold. Industry: Investing.
Offering
- Filed: 2022-02-23
- Form: D
- Accession: 0001912877-22-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $224K
- Remaining: $27K
- Minimum investment: $1K
- Investors: 15
- Date of first sale: 2022-02-15
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-434606
Issuer
- Name: Bioverge Funds, Octant I, LLC
- CIK: 0001912877
- Entity type: Limited Liability Company
- Jurisdiction: IDAHO
- Incorporated: 2022
- Address: 222 N 13TH ST, BOISE, ID, 83702
- Phone: 2086961262
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Neil - Bioverge Funds Management, LLC - Littman | Executive Officer | San Francisco, CA |
More